* ADVANCED ACCELERATOR APPLICATIONS - ‍ INTENDS TO FILE A FORM 25 WITH SEC NO EARLIER THAN 10 DAYS FROM JAN 22, TO EFFECT DELISTING, WITHDRAWAL * ADVANCED ACCELERATOR APPLICATIONS-NOT ARRANGED FOR ...

NEW YORK, Nov. 13, 2015 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq:NDAQ) announced that trading of Advanced Accelerator Applications S.A. (Nasdaq:AAAP), a radiopharmaceutical company based in ...

SAINT-GENIS-POUILLY, France, Oct. 30, 2017 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (AAA or the Company), a leader in nuclear medicine theragnostics, today announced ...

When Novartis shelled out $3.9 billion for France-based Advanced Accelerator Applications in 2017, it had blockbuster hopes for AAA’s Lutathera, a radiotherapy to treat neuroendocrine tumors (NETs).

(RTTNews) - As per a report published in the Financial Times, Siemens Healthineers (SMMNY.PK) is planning to buy Advanced Accelerator Applications, a Novartis company, which is focused exclusively on ...

The U.K.’s drug marketing watchdog, the PMCPA, is having a busy summer. It flagged five companies for an array of breaches of its code, and, in fact, two of them were hit with PMCPA's most harsh ...

It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment opportunity. As a result, most investors pick ...

Siemens Healthineers aims to grow its PET imaging business by picking up the radiodiagnostic manufacturing and distribution network of Novartis’ Advanced Accelerator Applications division. First ...

Novartis AG has proposed buying radiopharmaceuticals specialist Advanced Accelerator Applications SA (AAA) in a deal valuing the company at $3.9 billion. The transaction would add the EU-approved ...

Note: Articles may be assigned to more than one subject area, as a result the sum of the subject research outputs may not equal the overall research outputs. Note: Hover over the donut graph to view ...